human uacc812 bc cell lines  (ATCC)

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Associations between SGLT1 protein expression levels and clinicopathologic variables of the breast cancer patient cohort.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: Expressing

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Representative staining of SGLT1 in different subtypes of breast cancer (×100, ×400). (a) Negative immunoreactions. Scale bar: 100 μ m. (b) Positive staining of SGLT1 in luminal-like breast cancer. (c) Positive staining of SGLT1 in HER2+ breast cancer. (d) Positive staining of SGLT1 in basal-like breast cancer.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: Staining

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Representative western blot of HER2 and SGLT1 expression levels and quantification relative to actin in UACC812 and SKBR3 cells. UACC812 and SKBR3 cells were treated with HER2 inhibitors (HER2 I), Phlorizin, MG132 alone, or in combination for 48 h. Untreated cells were used as a negative control (NC). (a) A representative WB detection result of three independent experiments was shown. (b) The relative levels of HER2 and SGLT1 protein in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: Western Blot, Expressing, Negative Control

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: The curve and column results of the ECAR values for UACC812 and SKBR3 cells. (a) The ECAR values of UACC812 and SKBR3 cells treated with 0, 10, 20, 30, 40, 50, and 60 min, respectively. (b) The ECAR values of each group at 40 min in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques:

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Representative western blot of PI3K/Akt/mTOR pathway-related protein expression levels and quantification relative to actin in UACC812 cells. A representative WB detection result of PI3K/Akt/mTOR pathway-related protein expression levels in (a) SGLT1 siRNA and (d) phlorizin treatment. The relative levels of PI3K/Akt/mTOR protein in (b) SGLT1 siRNA and (e) phlorizin treatment. The relative levels of p-PI3K/p-Akt/p-mTOR protein in (c) SGLT1 siRNA and (f) phlorizin treatment. The results shown were representative of at least three independent experiments; ∗∗∗∗ p < 0.0001.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: Western Blot, Expressing

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: CCK-8 assays for the effect of SGLT1 expression on cell proliferation in UACC812 and SKBR3 cells. (a) The cell viability of UACC812 and SKBR3 cells relative to negative control groups after 0, 12, 24, 36, and 48 h treatment, respectively. (b) The cell viability of each group relative to negative control groups at 48 h in UACC812 and SKBR3 cells. Statistically significant differences between groups were displayed; ∗∗∗∗ p < 0.0001; ∗∗∗ p < 0.001; ∗∗ p < 0.01; ∗ p < 0.05.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: CCK-8 Assay, Expressing, Negative Control

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Cox's univariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques:

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Kaplan-Meier survival analysis according to SGLT1 expression in the whole cohort and HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (c) OS in the whole cohort of breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (d) OS in HER2+ breast cancer patients.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: Expressing

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Kaplan-Meier survival analysis according to SGLT1 expression in basal-like, luminal-like, and luminal-HER2+ subtype of breast cancer patients (log-rank test). Association of SGLT1 expression levels with (a) DFS and (d) OS in basal-like breast cancer patients. Association of SGLT1 expression levels with (b) DFS and (e) OS in luminal-like breast cancer patients. Association of SGLT1 expression levels with (c) DFS and (f) OS in LuminalHER2+ breast cancer patients.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques: Expressing

Journal: Disease Markers

Article Title: Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer

doi: 10.1155/2020/6103542

Figure Lengend Snippet: Cox's multivariate regression analysis of the patient survival in breast cancer with respect to clinical parameters and cancer biological factors.

Article Snippet: The HER2+ breast cancer cell lines UACC812 and SKBR3 were originally purchased from the American Type Culture Collection (Manassas, VA, USA) and authenticated by short tandem repeat analysis.

Techniques:

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Upregulation of ER signaling as an adaptive mechanism of cell survival in HER2-positive breast tumors treated with anti-HER2 therapy

doi: 10.1158/1078-0432.CCR-14-2728

Figure Lengend Snippet: A. Expression levels of ER, Bcl2, and PR in UACC812 tumor xenografts grown only in the presence of estrogen (E2; n=6) and treated with lapatinib in the presence of E2 (E2 + L; n=6). L-treated tumors showed a significant increase in the expression of ER, PR, and Bcl2, compared with tumors treated with vehicle.

Article Snippet: Cell line culture conditions and drugs for in vitro studies The human breast cancer cell line UACC812, originally purchased from the American Type Culture Collection (Manassas, VA, USA), was cultured as previously reported ( 6 ).

Techniques: Expressing

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Article Title: Upregulation of ER signaling as an adaptive mechanism of cell survival in HER2-positive breast tumors treated with anti-HER2 therapy

doi: 10.1158/1078-0432.CCR-14-2728

Figure Lengend Snippet: A. Tumor cell growth relative to control (DMSO) evaluated by methylene blue assay after 6 days of treatment with DMSO, ABT-737 (1 μM), fulvestrant (Ful; 0.1 μM), or the combination of ABT-737 with Ful, in parental and lapatinib (L)-resistant UACC812 cells.

Article Snippet: Cell line culture conditions and drugs for in vitro studies The human breast cancer cell line UACC812, originally purchased from the American Type Culture Collection (Manassas, VA, USA), was cultured as previously reported ( 6 ).

Techniques: Control